Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia

Annals of Hematology

Volumn 93, Issue 3, 2014, Pages 425-435

  Zhu, Huayuan ^a   Wu, Wei ^a   Fu, Yuan ^a   Shen, Wenyi ^a   Miao, Kourong ^a   Hong, Min ^a   Xu, Wei ^a   Young, Ken H ^b   Liu, Peng ^a   Li, Jianyong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; BAG3; Cell migration; Chronic lymphocytic leukemia

Indexed keywords

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL MOVEMENT; FEMALE; FOLLOW-UP STUDIES; GENE SILENCING; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84894315232     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1883-1     Document Type: Article

References (45)

1. Chiorazzi N, Rai KR, Ferrarini M (2005) Chronic lymphocytic leukemia. N Engl J Med 352:804-815
2. Berkova A, Pavlistova L, Babicka L et al (2008) Combined molecular biological and molecular cytogenetic analysis of genomic changes in 146 patients with B-cell chronic lymphocytic leukemia. Neoplasma 55:400-408
3. Cramer P, Hallek M (2011) Prognostic factors in chronic lymphocytic leukemia - what do we need to know? Nat Rev Clin Oncol 8:38-47
4. Capitani N, Baldari CT (2010) The Bcl-2 family as a rational target for the treatment of B-cell chronic lymphocytic leukaemia. Curr Med Chem 17:801-811
5. Takayama S, Sato T, Krajewski S et al (1995) Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80:279-284
6. Doong H, Vrailas A, Kohn EC (2002) What's in the 'BAG'? - a functional domain analysis of the BAG-family proteins. Cancer Lett 188:25-32
7. Takayama S, Reed JC (2001) Molecular chaperone targeting and regulation by BAG family proteins. Nat Cell Biol 3:E237-E241
8. Kassis JN, Guancial EA, Doong H, Virador V, Kohn EC (2006) CAIR-1/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins. Exp Cell Res 312:2962-2971
9. Takayama S, Xie Z, Reed JC (1999) An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J Biol Chem 274:781-786
10. Bonelli P, Petrella A, Rosati A et al (2004) BAG3 protein regulates stress-induced apoptosis in normal and neoplastic leukocytes. Leukemia 18:358-360
11. Chiappetta G, Ammirante M, Basile A et al (2007) The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Clin Endocrinol Metab 92:1159-1163
12. Liao Q, Ozawa F, Friess H et al (2001) The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines. FEBS Lett 503:151-157
13. Staibano S, Mascolo M, Di Benedetto M et al (2010) BAG3 protein delocalisation in prostate carcinoma. Tumour Biol 31:461-469
14. Iwasaki M, Homma S, Hishiya A et al (2007) BAG3 regulates motility and adhesion of epithelial cancer cells. Cancer Res 67:10252-10259
15. Suzuki M, Iwasaki M, Sugio A et al (2011) BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells. Cancer Lett 303:65-71
16. Romano MF, Festa M, Pagliuca G et al (2003) BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis. Cell Death Differ 10:383-385
17. Romano MF, Festa M, Petrella A et al (2003) BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cells. Cancer Biol Ther 2:508-510
18. Liu P, Xu B, Li J, Lu H (2009) BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis. FEBS Lett 583:401-406
19. Wang HQ, Liu HM, Zhang HY, Guan Y, Du ZX (2008) Transcriptional upregulation of BAG3 upon proteasome inhibition. Biochem Biophys Res Commun 365:381-385
20. Valdez BC, Murray D, Ramdas L et al (2008) Altered gene expression in busulfan-resistant human myeloid leukemia. Leuk Res 32:1684-1697
21. Chen HY, Liu P, Sun M et al (2010) Bag3 gene expression in chronic lymphocytic leukemia and its association with patients' prognosis. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18:838-842
22. Zhu H, Liu P, Li J (2012) BAG3: a new therapeutic target of human cancers? Histol Histopathol 27:257-261
23. Anonymous (2004) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Int Bioethique 15:124-129
24. Hallek M, Cheson BD, Catovsky D et al (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111:5446-5456
25. Keating MJ, O'Brien S, Kontoyiannis D et al (2002) Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia. Leuk Lymphoma 43:1755-1762
26. Xu W, Li JY, Wu YJ et al (2008) Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia. Leuk Res 32:1071-1077
27. Dong HJ, Zhou LT, Zhu DX et al (2011) The prognostic significance of TP53 mutations in Chinese patients with chronic lymphocytic leukemia is independent of del(17p13). Ann Hematol 90:709-717
28. Buggins AG, Pepper CJ (2010) The role of Bcl-2 family proteins in chronic lymphocytic leukaemia. Leuk Res 34:837-842
29. Seo YJ, Jeon MH, Lee JH et al (2005) Bis induces growth inhibition and differentiation of HL-60 cells via up-regulation of p27. Exp Mol Med 37:624-630
30. Rosati A, Di Salle E, Luberto L et al (2009) Identification of a Btk-BAG3 complex induced by oxidative stress. Leukemia 23:823-824
31. Cesaro E, Montano G, Rosati A et al (2010) WT1 protein is a transcriptional activator of the antiapoptotic bag3 gene. Leukemia 24:1204-1206
32. Krober A, Seiler T, Benner A et al (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100:1410-1416
33. Jelinek DF, Tschumper RC, Geyer SM et al (2001) Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Haematol 115:854-861
34. Hayat A, O'Brien D, O'Rourke P et al (2006) CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia. Leuk Lymphoma 47:2371-2379
35. Rosenwald A, Alizadeh AA, Widhopf G et al (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194:1639-1647
36. Wiestner A, Rosenwald A, Barry TS et al (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101:4944-4951
37. Dohner H, Fischer K, Bentz M et al (1995) p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 85:1580-1589
38. Lin K, Sherrington PD, Dennis M et al (2002) Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. Blood 100:1404-1409
39. Lee JH, Takahashi T, Yasuhara N et al (1999) Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death. Oncogene 18:6183-6190
40. Jacobs AT, Marnett LJ (2009) HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins. J Biol Chem 284:9176-9183
41. Ammirante M, Rosati A, Arra C et al (2010) IKKγ protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci USA 107:7497-7502
42. Du ZX, Meng X, Zhang HY, Guan Y, Wang HQ (2008) Caspase-dependent cleavage of BAG3 in proteasome inhibitors-induced apoptosis in thyroid cancer cells. Biochem Biophys Res Commun 369:894-898
43. Wang HQ, Liu BQ, Gao YY et al (2009) Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression. Br J Pharmacol 158:1405-1412
44. Aveic S, Pigazzi M, Basso G (2011) BAG1: the guardian of anti-apoptotic proteins in acute myeloid leukemia. PLoS One 6:e26097
45. Iwasaki M, Tanaka R, Hishiya A et al (2010) BAG3 directly associates with guanine nucleotide exchange factor of Rap1, PDZGEF2, and regulates cell adhesion. Biochem Biophys Res Commun 400:413-418